Afatinib
Product Specifications
Background
Afatinib is a clinically useful kinase inhibitor approved for the treatment of non-small cell lung cancer. It is a potent and highly selective inhibitor of mutant and wild-type EGFR (IC50 = 0.5 nM) and HER2 (IC50 = 14 nM) .
Conjugation
Unconjugated
Buffer
Pale yellow solid
Storage Conditions
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
